Anand Kiran Parikh

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Austin, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Josiah Craver, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Anand Kiran Parikh

Form 4 holding President and CEO, Director

Faeth Therapeutics, Inc.

Security class
Performance-Based Stock Option (right to buy)
Shares / value
398,018
Estimated value
Report date
21 Jul 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Faeth Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
4,107
Estimated value
Report date
22 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Anand Kiran Parikh

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .